Literature DB >> 22355221

Genome-wide integrative analysis revealed a correlation between lengths of copy number segments and corresponding gene expression profile.

Ken Miyaguchi, Yutaka Fukuoka, Hiroshi Mizushima, Mahmut Yasen, Shota Nemoto, Toshiaki Ishikawa, Hiroyuki Uetake, Shinji Tanaka, Kenichi Sugihara, Shigeki Arii, Hiroshi Tanaka.   

Abstract

Microarray analysis has been applied to comprehensively reveal the abnormalities of DNA copy number (CN) and gene expression in human cancer research during the last decade. These analyses have individually contributed to identify the genes associated with carcinogenesis, progression, metastasis of tumor cells and poor prognosis of cancer patients. However, it is known that the correlation between profiles of CN and gene expression does not highly correlate. Factors which determine the degree of correlation remain largely unexplained. To investigate one such factor, we performed trend analyses between the lengths of CN segments and corresponding gene expression profiles from microarray data in hepatocellular carcinoma (HCC) and colorectal carcinoma (CRC). Significant correlations were observed in CN gain of HCC and CRC (p<0.05). The trend of the CN loss showed a significant correlation in HCC although there was no correlation between the length of CN loss segments and gene expression in CRC. Our findings suggest that the influence of CN on gene expression highly depends on the length of CN region, especially in the case of CN gain. To the best of our knowledge, this is the first study describing the correlation between lengths of CNA segments and expression profiles of corresponding genes.

Entities:  

Keywords:  colorectal carcinoma; copy number alteration; gene expression; hepatocellular carcinoma; microarray

Year:  2011        PMID: 22355221      PMCID: PMC3280495          DOI: 10.6026/97320630007280

Source DB:  PubMed          Journal:  Bioinformation        ISSN: 0973-2063


  13 in total

Review 1.  Chromatin structure of eukaryotic promoters: a changing perspective.

Authors:  Philippe T Georgel
Journal:  Biochem Cell Biol       Date:  2002       Impact factor: 3.626

Review 2.  Determinants and dynamics of genome accessibility.

Authors:  Oliver Bell; Vijay K Tiwari; Nicolas H Thomä; Dirk Schübeler
Journal:  Nat Rev Genet       Date:  2011-07-12       Impact factor: 53.242

3.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

Review 4.  Chromatin higher-order structures and gene regulation.

Authors:  Guohong Li; Danny Reinberg
Journal:  Curr Opin Genet Dev       Date:  2011-02-20       Impact factor: 5.578

Review 5.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

6.  Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs.

Authors:  George L Jackson; L Douglas Melton; David H Abbott; Leah L Zullig; Diana L Ordin; Steven C Grambow; Natia S Hamilton; S Yousuf Zafar; Ziad F Gellad; Michael J Kelley; Dawn Provenzale
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

Review 7.  Cancer epigenetics comes of age.

Authors:  P A Jones; P W Laird
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

8.  Integrative analysis of genomic aberrations associated with prostate cancer progression.

Authors:  Jung H Kim; Saravana M Dhanasekaran; Rohit Mehra; Scott A Tomlins; Wenjuan Gu; Jianjun Yu; Chandan Kumar-Sinha; Xuhong Cao; Atreya Dash; Lei Wang; Debashis Ghosh; Kerby Shedden; James E Montie; Mark A Rubin; Kenneth J Pienta; Rajal B Shah; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

9.  Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Nikolaos M Sitaras
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

10.  Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays.

Authors:  Mitchell Guttman; Carolyn Mies; Katarzyna Dudycz-Sulicz; Sharon J Diskin; Don A Baldwin; Christian J Stoeckert; Gregory R Grant
Journal:  PLoS Genet       Date:  2007-08       Impact factor: 5.917

View more
  2 in total

1.  JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.

Authors:  Malabika Sen; Netanya I Pollock; John Black; Kara A DeGrave; Sarah Wheeler; Maria L Freilino; Sonali Joyce; Vivian W Y Lui; Yan Zeng; Simion I Chiosea; Jennifer R Grandis
Journal:  Neoplasia       Date:  2015-03       Impact factor: 5.715

2.  Short somatic alterations at the site of copy number variation in breast cancer.

Authors:  Fumi Murakami; Yumi Tsuboi; Yuka Takahashi; Yoshiya Horimoto; Kaoru Mogushi; Takeshi Ito; Mitsuru Emi; Daisuke Matsubara; Tatsuhiro Shibata; Mitsue Saito; Yoshinori Murakami
Journal:  Cancer Sci       Date:  2020-12-11       Impact factor: 6.518

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.